comparemela.com

Latest Breaking News On - இருதய தலையீடுகள் - Page 7 : comparemela.com

Microsurgery effective in treating varicose veins

Microsurgery effective in treating varicose veins LOWER RISKS: Laser and VenaSeal have a 95% to 98% success rate in treating varicose veins, which, if left untreated, could cause blood clots and artery diseases By Wu Liang-yi and Jonathan Chin / Staff reporter, with staff writer Taoyuan Chang Gung Medical Hospital on Tuesday announced two novel microsurgery procedures to treat varicose veins, a condition that could cause artery diseases and potentially lethal blood clots if left untreated. Less than 1 percent of Taiwanese with varicose veins seek treatment, said Chang Shyue-luen (張學倫), a dermatologist at the hospital. This unwillingness to seek treatment could turn into a serious health problem, because varicose veins could lead to swelling, pain, ulcers and the formation of blood clots that could be lethal if they travel to the lungs, he said.

ECG Flags COVID Mortality; ICDs & Depression; Pre-Conception Test for Heart Disease?

Journal of the American College of Cardiology) Stroke survivors trying to regain arm function in rehabilitation found incremental improvement with vagus nerve stimulation in the VNS-REHAB trial. ( The Lancet) The American College of Physicians released a guideline on the use of point-of-care ultrasound for patients with acute dyspnea. A theory posits that dual SGLT1 and SGLT2 inhibition could improve cardiovascular outcomes for people with diabetes. ( Circulation) Philips Stellarex paclitaxel drug-coated balloon did not increase deaths at 5 years over percutaneous transluminal angioplasty in a 600-patient meta-analysis supporting its safety. Clotting drug tranexamic acid did not raise complication rates for high-risk patients undergoing orthopedic surgeries. (

Royal Philips: Five-year patient-level meta-analysis of ILLUMENATE EU RCT and Pivotal study results confirms safety profile of Philips Stellarex 035 low-dose Drug-Coated Balloon

Royal Philips: Five-year patient-level meta-analysis of ILLUMENATE EU RCT and Pivotal study results confirms safety profile of Philips Stellarex 035 low-dose Drug-Coated Balloon
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

ACP and AHA partner on new open access journal-Annals of Internal Medicine: Clinical Cases

Share this article PHILADELPHIA, April 15, 2021 /PRNewswire/ The American College of Physicians (ACP), publisher of Annals of Internal Medicine (Annals), one of the most influential peer-reviewed clinical journals in the world, and the American Heart Association (AHA) today announce a new partnership to jointly publish Annals of Internal Medicine: Clinical Cases (AIMCC). The digital, open access, peer-reviewed journal will publish case reports relevant to clinicians across the spectrum of medicine. Clinicians say that they often learn valuable lessons by discussing clinical experiences and observations with their colleagues, said Darilyn V. Moyer, MD, executive vice president and chief executive officer of ACP.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.